Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Flex Pharma, Inc. (FLKS)
Flex Pharma, Inc. (FLKS) Actualités

FLKS

FLEX PHARMA, INC. (FLKS)

Flex Pharma, Inc.

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:FLKS

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
12/11/2019	22h35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FLKS	Flex Pharma, Inc.
28/10/2019	13h33	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:FLKS	Flex Pharma, Inc.
28/10/2019	13h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
18/09/2019	23h03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:FLKS	Flex Pharma, Inc.
18/09/2019	22h56	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:FLKS	Flex Pharma, Inc.
14/09/2019	00h32	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:FLKS	Flex Pharma, Inc.
14/09/2019	00h31	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:FLKS	Flex Pharma, Inc.
13/09/2019	12h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLKS	Flex Pharma, Inc.
29/07/2019	23h28	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:FLKS	Flex Pharma, Inc.
24/07/2019	01h54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLKS	Flex Pharma, Inc.
18/07/2019	23h06	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLKS	Flex Pharma, Inc.
12/07/2019	22h05	Business Wire	Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting	NASDAQ:FLKS	Flex Pharma, Inc.
27/06/2019	12h03	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:FLKS	Flex Pharma, Inc.
25/06/2019	13h00	Business Wire	Flex Pharma Announces Broker Authority to Vote on Certain Proposals	NASDAQ:FLKS	Flex Pharma, Inc.
20/05/2019	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:FLKS	Flex Pharma, Inc.
01/05/2019	13h00	Business Wire	Flex Pharma Reports First Quarter 2019 Financial Results	NASDAQ:FLKS	Flex Pharma, Inc.
29/04/2019	21h23	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:FLKS	Flex Pharma, Inc.
24/04/2019	22h16	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:FLKS	Flex Pharma, Inc.
18/04/2019	12h01	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:FLKS	Flex Pharma, Inc.
16/04/2019	22h13	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:FLKS	Flex Pharma, Inc.
06/03/2019	23h09	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:FLKS	Flex Pharma, Inc.
06/03/2019	22h14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:FLKS	Flex Pharma, Inc.
06/03/2019	13h00	Business Wire	Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results	NASDAQ:FLKS	Flex Pharma, Inc.
14/02/2019	12h22	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:FLKS	Flex Pharma, Inc.
12/02/2019	21h50	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:FLKS	Flex Pharma, Inc.
05/02/2019	16h05	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:FLKS	Flex Pharma, Inc.
04/01/2019	13h00	Business Wire	Flex Pharma & Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Thera...	NASDAQ:FLKS	Flex Pharma, Inc.
21/12/2018	23h17	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:FLKS	Flex Pharma, Inc.
06/12/2018	09h30	PR Newswire (US)	Asceneuron Appoints Dr. Thomas C. Wessel as Chief Medical Officer	NASDAQ:FLKS	Flex Pharma, Inc.
05/11/2018	13h00	Business Wire	Flex Pharma Reports Third Quarter 2018 Financial Results	NASDAQ:FLKS	Flex Pharma, Inc.

Showing the most relevant articles for your search:NASDAQ:FLKS

1 2 3 4 5 Suivant >>

Fin.res.ser1a3s

NLBNPIT1T3V0 20241220 17

NLBNPIT1ZV63 20991231 11...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales